【结 构 式】 |
【分子编号】38983 【品名】2-bromo-2-(2-methylphenyl)acetic acid 【CA登记号】 |
【 分 子 式 】C9H9BrO2 【 分 子 量 】229.07326 【元素组成】C 47.19% H 3.96% Br 34.88% O 13.97% |
合成路线1
该中间体在本合成路线中的序号:(XI)In a related procedure, alkylation of 2,4-dihydroxybenzaldehyde (VI) with chloride (II) gave ether (VII). Subsequent conversion of the aldehyde group of (VII) into the desired nitrile (X) was effected by the following sequence, including formation of the corresponding oxime (VIII), dehydration with concomitant acetylation using Ac2O, and then hydrolysis of acetate (IX) using K2CO3. Alternatively, aldehyde (VII) was directly converted to nitrile (X) by reaction with hydroxylamine-O-sulfonic acid, followed by basic treatment. Racemic alpha-bromo-(2-methylphenyl)acetic acid (XI) was resolved via formation of the corresponding salt with (-)-ephedrine (XII). Hydroxy nitrile (X) was then alkylated with the chiral bromide (XII), and the resulting compound was finally converted to the corresponding sodium salt.
【1】 Porter, B.; Astles, P.C.; Bridge, A.W.; McLay, I.M.; Van Sickle, A.P.; Walsh, R.J.A.; McCarthy, C.; Morley, A.D.; Halley, F.; Harris, N.V.; Majid, T.N.; Smith, C. (Rhône-Poulenc Rorer Ltd.); Substd. phenyl cpds. as endothelin antagonists. US 6048893; US 6124343; WO 9622978 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(II) | 28617 | 5-(chloromethyl)-1,3-benzodioxole | C8H7ClO2 | 详情 | 详情 | |
(VI) | 20094 | 2,4-dihydroxybenzaldehyde | 95-01-2 | C7H6O3 | 详情 | 详情 |
(VII) | 38979 | 4-(1,3-benzodioxol-5-ylmethoxy)-2-hydroxybenzaldehyde | C15H12O5 | 详情 | 详情 | |
(VIII) | 38980 | 4-(1,3-benzodioxol-5-ylmethoxy)-2-hydroxybenzaldehyde oxime | C15H13NO5 | 详情 | 详情 | |
(IX) | 38981 | 5-(1,3-benzodioxol-5-ylmethoxy)-2-cyanophenyl acetate | C17H13NO5 | 详情 | 详情 | |
(X) | 38982 | 4-(1,3-benzodioxol-5-ylmethoxy)-2-hydroxybenzonitrile | C15H11NO4 | 详情 | 详情 | |
(XI) | 38983 | 2-bromo-2-(2-methylphenyl)acetic acid | C9H9BrO2 | 详情 | 详情 | |
(XII) | 38984 | (2R)-2-bromo-2-(2-methylphenyl)ethanoic acid | C9H9BrO2 | 详情 | 详情 |